The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Estimated Market Size Of The Predictive Biomarkers Market During 2026–2030?
The predictive biomarkers market has experienced consistent growth in recent years. Its valuation is set to rise from $20.96 billion in 2025 to $21.88 billion by 2026, achieving a compound annual growth rate (CAGR) of 4.4%. Historically, this expansion has been propelled by factors including the advancement of genomic research, an increase in targeted therapies, the growing prevalence of cancer, the wider adoption of molecular diagnostics, and supportive regulatory environments for biomarkers.
The predictive biomarkers market is anticipated to experience consistent expansion over the coming years. By 2030, this market is projected to reach $25.65 billion, demonstrating a compound annual growth rate (CAGR) of 4.0%. This anticipated growth during the forecast period is attributable to several factors, including advancements in multi-omics technologies, the widening scope of personalized medicine, increased pharmaceutical research and development expenditures, a rising demand for predictable treatment outcomes, and the integration of biomarkers into standard healthcare practices. Key trends expected within this period involve the expansion of precision oncology applications, increased utilization in stratifying drug responses, a greater emphasis on biomarker-based clinical trial designs, the growing adoption of companion diagnostics, and the standardization of biomarker validation protocols.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20595&type=smp
What Underlying Factors Are Accelerating The Growth Of The Predictive Biomarkers Market?
The increasing incidence of cancer is anticipated to propel the expansion of the predictive biomarkers market in the coming years. Cancer is defined as a disease marked by uncontrolled cell growth capable of invading and spreading to other parts of the body. The escalation in cancer cases is primarily attributable to aging populations, shifts in lifestyle, and greater exposure to risk factors such as tobacco, unhealthy diets, and environmental pollutants. Predictive biomarkers in oncology are instrumental in identifying patients who are likely to respond to specific treatments, thereby facilitating personalized and more effective therapy. For instance, in April 2024, a report from the International Agency for Research on Cancer (IARC), a France-based specialized agency of the World Health Organization (WHO) dedicated to cancer research, revealed nearly 20 million new cancer cases and approximately 10 million cancer-related deaths occurred in 2022. Furthermore, projections indicate that the annual number of new cancer cases is expected to increase to 35 million by 2050, signifying a 77% rise from 2022 levels. Consequently, the increasing prevalence of cancer will drive the growth of the predictive biomarkers market.
How Are The Various Segments Of The Predictive Biomarkers Market Categorized?
The predictive biomarkers market covered in this report is segmented –
1) By Indication: Cancer, Metabolic Disease, Cardiovascular Disorder, Immunological Disorder, Other Indications
2) By Application: Screening, Analysis, Diagnosis, Prediction, Monitoring
3) By End User: Diagnostic Centers, Contract Research Organizations, Academic Research Institutes, Pharms And Biotech Companies, Other End Users
Subsegments:
1) By Cancer: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Ovarian Cancer, Leukemia And Lymphoma, Melanoma, Pancreatic Cancer, Kidney Cancer, Head And Neck Cancer
2) By Metabolic Disease: Type 1 And Type 2 Diabetes, Obesity, Metabolic Syndrome, Non-Alcoholic Fatty Liver Disease (NAFLD), Dyslipidemia, Insulin Resistance
3) By Cardiovascular Disorder: Atherosclerosis, Coronary Artery Disease, Heart Failure, Myocardial Infarction (Heart Attack), Arrhythmia, Hypertension, Stroke, Peripheral Arterial Disease
4) By Immunological Disorder: Autoimmune Diseases, Inflammatory Bowel Disease (Ibd), Multiple Sclerosis, Psoriasis, Allergic Diseases, Asthma, Chronic Obstructive Pulmonary Disease (Copd), Immunodeficiency Disorders
5) By Other Indications: Neurological Disorders, Infectious Diseases, Renal Diseases, Osteoarthritis, Genetic Disorders, Respiratory Disorders
What Trends Are Affecting The Expansion Of The Predictive Biomarkers Market?
Companies operating within the predictive biomarkers market are prioritizing the acceleration of biomarker development through technological advancements, such as artificial intelligence (AI)-driven biomarker discovery, aiming to gain a competitive edge by delivering more personalized and effective therapies faster. AI-driven biomarker discovery facilitates the analysis of extensive, complex datasets, leading to the identification of predictive biomarkers that might not be evident through conventional methods. For instance, in July 2024, Scipher Medicine, Inc., a US-based precision immunology company, introduced PRoBeNet (Predictive Response Biomarkers using Network Medicine). This system aims to expedite the development of predictive response biomarkers for complex diseases using AI and network biology. PRoBeNet identifies biomarkers of therapy response by integrating therapy-targeted proteins and disease-specific molecular signatures. Its validation has occurred for autoimmune diseases such as rheumatoid arthritis, ulcerative colitis, and Crohn’s disease, with potential application to other complex diseases and drug development phases.
Which Major Firms Influence Developments In The Predictive Biomarkers Market?
Major companies operating in the predictive biomarkers market are Johnson & Johnson Services Inc, F Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthcare GmbH, Agilent Technologies Inc, PerkinElmer Inc, Illumina Inc, Bio-Rad Laboratories Inc, QIAGEN GmbH, Almac Group Limited, ArcherDX Inc, Luminex Corporation, Guardant Health Inc, Meso Scale Diagnostics LLC, Myriad Genetics Inc, NanoString Technologies Inc, Fujirebio Inc, Asuragen Inc, Biognosys AG, Epigenomics AG, OncoCyte Corporation, Biomarker Technologies Inc
Read the full predictive biomarkers market report here:
https://www.thebusinessresearchcompany.com/report/predictive-biomarkers-global-market-report
Which Region Is Projected To Dominate The Predictive Biomarkers Market During The Forecast Period?
North America was the largest region in the predictive biomarkers market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Predictive Biomarkers Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20595&type=smp
Browse Through More Reports Similar to the Global Predictive Biomarkers Market 2026, By The Business Research Company
Renal Biomarkers Market Report 2026
https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report
Cancer Biomarker Market Report 2026
https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report
Non Alcoholic Steatohepatitis Biomarkers Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model